Showing posts with label RoActemraActemra. Show all posts
Showing posts with label RoActemraActemra. Show all posts

Wednesday, 3 July 2013

A Study to Compare Subcutaneous Versus Intravenous Administration of RoActemra/Actemra (Tocilizumab) in Patients with Moderate to Severe Active Rheumatoid Arthritis